Zenomics logo — Pioneering a smart patch for diabetes that automatically bal...

Zenomics

Pioneering a smart patch for diabetes that automatically balances blood glucose and insulin levels.

Founded 2015 Venture round Total: $2.80M Biotechnology, Health Care

General Information

Company Name Zenomics
Founded Year 2015
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Zenomics. To contact Zenomics, visit zenomicsbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Zenomics compare?

A PDF of Zenomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Zenomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Zenomics

Zenomics is a biotechnology and healthcare startup that is pioneering a smart patch for diabetes management, with the ability to autonomously balance blood glucose and insulin levels. The company was founded in 2015 and is based in Durham, North Carolina. Their innovative microneedle transdermal patch can monitor blood glucose levels and administer the correct doses of insulin, offering a promising solution for diabetes patients. In June 2017, Zenomics secured a significant $2.80M in a Venture Round investment, indicating strong investor interest and potential for growth in the digital health market. With the ongoing advancements in healthcare technology, Zenomics' pioneering approach and potential impact make it an intriguing prospect for venture capitalists seeking to invest in groundbreaking solutions for chronic health conditions.

Business keywords: Diabetes management, Smart patch technology, Microneedle transdermal patch, Insulin delivery, Blood glucose monitoring, Drug delivery technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $2.80M -
12 Jun 2017

Zenomics Alternatives & Competitors

View All Alternatives
Zenomics vs

Enhancing insulin therapy with personalized recommendations for improved glycemic control through a...

Series B
11-50 employees
Biotechnology, Health Care
Zenomics vs
Valeritas
Valeritas United States

Improving health and simplifying life for people with diabetes.

Venture round
35 employees
Biotechnology, Health Care
Zenomics vs
Echo Therapeutics
Echo Therapeutics United States

Echo Therapeutics is developing its non-invasive, wireless, continuous glucose monitoring (CGM) syst...

Post-IPO Debt
8 employees
Biotechnology, Health Care

FAQ About Zenomics

Pioneering a smart patch for diabetes that automatically balances blood glucose and insulin levels.
Zenomics was founded in 2015.
Zenomics operates in Biotechnology and Health Care. Its work centres on Diabetes management, Smart patch technology, Microneedle transdermal patch and Insulin delivery.
Zenomics has completed 1 funding round, raising a total of $2.80M. The latest funding stage is Venture round.
Top alternatives and competitors to Zenomics include HYGIEIA, Valeritas, Echo Therapeutics, Portal Diabetes, Inc., Intuity Medical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zenomics and HYGIEIA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Zenomics, https://bouncewatch.com/company/zenomics, updated 13 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes